• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Henry Schein (HSIC) Looks Fairly Valued On Leadership Reshuffle and Supply Chain Changes

    Simply Wall St·08/02/2026 07:22:10
    Listen to the news

    Henry Schein (HSIC) is reshaping its leadership structure after announcing the new Henry Schein Leadership Team to replace its Executive Management Committee and integrating its global supply chain group with its global distribution operations.

    See our latest analysis for Henry Schein.

    Over the past year, Henry Schein has seen building momentum, with a 90 day share price return of 15.99% and a 1 year total shareholder return of 26.14% at a share price of US$85.75.

    If leadership changes have you reassessing opportunities in healthcare, it can help to widen your scope and review stocks in other fast evolving areas such as 41 healthcare AI stocks

    Henry Schein now trades at a sizeable discount to one estimate of fair value, even with shares already higher over recent months. Is that gap a sign of overly cautious sentiment, or a fair reflection of execution risk around the new leadership structure?

    Most Popular Narrative: 2.6% Undervalued

    With Henry Schein closing at $85.75 against a narrative fair value of $88.07, the current setup hinges on how its higher margin segments and cost programs play out.

    The company is experiencing strong growth in high-margin businesses such as Specialty Products, Technology, and private-label offerings, and expects over 50% of non-GAAP operating income to come from these segments, supporting structurally higher gross margins and likely driving earnings expansion. Investments in digital workflow, AI solutions, and integrated cloud-based practice management platforms are accelerating recurring SaaS revenues and client retention, positioning Henry Schein to benefit from the ongoing digital transformation of healthcare, which should support both revenue growth and improved margins.

    Read the complete narrative.

    Want to see what sits behind that earnings expansion story? The narrative leans heavily on margin mix, recurring software revenue and a lower future earnings multiple. The key question is how those ingredients combine to justify fair value just above today’s price.

    Result: Fair Value of $88.07 (UNDERVALUED)

    Have a read of the narrative in full and understand what's behind the forecasts.

    However, Henry Schein still faces risks related to competitive pricing pressure in key consumables and potential execution missteps as the new leadership and cost programs bed in.

    Find out about the key risks to this Henry Schein narrative.

    Next Steps

    This mix of opportunity and concern around Henry Schein will mean different things to different investors, so move quickly and test the data against your own thesis. To weigh both sides in one place, start with the 2 key rewards and 1 important warning sign

    Looking for more investment ideas beyond Henry Schein?

    If you are reassessing your options after Henry Schein's recent moves, do not stop at a single stock. Broader research can reveal opportunities that fit your goals.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.